GSK submits quad flu, H5N1 vaccine applications
This article was originally published in Scrip
Executive Summary
Days after competitor AstraZeneca's MedImmune unit gained the US FDA's blessing for the first quadrivalent influenza vaccine in the US, GlaxoSmithKline revealed it has submitted applications seeking approval for its quad flu shot in the US and Europe (scripintelligence, 1 March 2012).